期刊文献+

EGFR靶向治疗的新观点及发展趋势 被引量:1

下载PDF
导出
作者 苏沐 姜藻
出处 《临床肿瘤学杂志》 CAS 2006年第6期471-474,478,共5页 Chinese Clinical Oncology
  • 相关文献

参考文献38

  • 1Mendelsohn J,Baselga J.Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer[J].J Clin Oncol,2003,21 (14):2787-2799.
  • 2Burtness B.The role of cetuximab in the treatment of squamous cell of head and neck[J].Expert Opin Bio Ther,2005,5(8):1085-1093.
  • 3Chong G,Cunningham D.The role of cetuximab in the therapy of previously treated advanced colorectal cancer[J].Semin Oncol,2005,32(6 Suppl 9):55-58.
  • 4Lynch TJ,Lilenbaum R,Bonomi P,et al.A phase Il trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC)[J].Proc Am Soc Clin Oncol,2004,23:634a.
  • 5Vanhoefer U,Tewes M,Rojo F,et al.Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor[J].J Clin Oncol,2004,22:175-184.
  • 6Agus DB,Gordon MS,Taylor C,et al.A phase I clinical study of pertuzumab,a novel HER dimerization inhibitor,in patients with advanced cancer[J].J Clin Oncol,2005,23:2534-2543.
  • 7Fukuoka M,Yano S,Giaccone G,et al.Multi-institutional randomized phase Ⅱ trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer[J].J Clin Oncol,2003,21:2237-2246.
  • 8Soulieres D,Senzer NN,Vokes EE,et al.Multicenter phase Ⅱ study of erlotinib,an oral epidermal growth factor receptor tyrosine kinase inhibitor,in patients with recurrent or metastatic squamous cell cancer of the head and neck[J].J Clin Oncol,2004,22(1):77-85.
  • 9Shepherd FA,Rodrigues Pereira J,Ciuleanu T,et al.Erlotinib in previously treated non-small-cell lung cancer[J].N Engl J Med,2005,353(2):123-132.
  • 10Tsao MS,Sakurada A,Cutz JC,et al.Erlotinib in lung cancer-molecular and clinical predictors of outcome[J].N Engl J Med,2005,353(2):133-144.

同被引文献19

  • 1彭涛,周家驹.表皮生长因子受体酪氨酸激酶抑制剂的药效团研究(英文)[J].计算机与应用化学,2005,22(6):431-436. 被引量:3
  • 2罗光顺,陆涛.EGFR酪氨酸激酶及其抑制剂的研究进展[J].海峡药学,2006,18(4):17-21. 被引量:2
  • 3Harold, M.; Chang, M.; Chen, P.; Dextraze, P.; Fink, B. E.; Gavai, A.; Goyal, B.; Han, W. C.; Johnson, W.; Langley, D.; Lee, F. Y.; Marathe, P.; Mathur, A.; Oppenheimer, S.; Ruediger, E.; Tarrant, J.; Tokarski, J. S.; Vite, G. D.; Vyas, D. M.; Wong, H. Bioorg. Med. Chem. Lett., 2007, 17(7): 2036.
  • 4Ballard, B.; Bradbury, R. H.; Harris, C. S.; Hennequin, L. F. A.; Hickinson, M.; Kettle, J. G.; Kendrew, J.; Klinowska, T.; Ogilvie, D. J.; Pearson, S. E.; Williams, E. J.; Wilson, I. Bioorg. Med. Chem. Lett., 2006, 16(18): 4908.
  • 5Fink, B. E.; Vite, G. D.; Mastalerz, H.; Kadow, J. F.; Kim, S. H.; Leavitt, K. J.; Du, K.; Crews, D.; Mitt, T.; Wong, T. W.; Hunt, J. T.; Vyas, D. M.; Tokarski, J. S. Bioorg. Med. Chem. Lett., 2005, 15(21): 4774.
  • 6Mastalerz, H.; Chang, M.; Gavai, A.; Johnson, W.; Langley, D.; Lee, F. Y.; Marathe, P.; Mathur, A.; Oppenheimer, S.; Tarrant, J.; Tokarski, J. S.; Vite, G. D.; Vyas, D. M.; Wong, H.; Wong, T. W.; Zhang, H. J.; Zhang G. F. Bioorg. Med. Chem. Lett., 2007, 17(10) 2828.
  • 7Ballard, P.; Bradbury, R. H.; Harris, C. S.; Hennequin, L. F. A.; Hickinson, M.; Johnson, P. D.; Kettle, J. G.; Klinowska, T.; Leach, A. G.; Morgentin, R.; Pass, M.; Ogilvie, D. J.; Olivier, A.; Warin, N.; Williams, E. J. Bioorg. Med. Chem. Lett., 2006, 16(6): 1633.
  • 8Laurent, F. A. H.; Peter, B.; Tom, B. F. Bioorg. Med. Chem. Lett., 2006, 16(10): 2672.
  • 9Waterson, A. G.; Stevens, K. L.; Reno, M. J.; Zhang, Y. M.; Boros, E. E.; Bouvier, F.; Rastagar, A.; Uehling, D. E.; Dickerson, S. H.; Reep, B. McDonald, O. B.; Wood, E. R.; Rusnak, D. W.; Alligood, K. J.; Rudolph, S. K. Bioorg. Med. Chem. Lett., 2006, 16(9): 2419.
  • 10Petrov, K. G.; Zhang, Y. M.; Carter, M.; Cockerill, G. S.;Dickerson, S.; Gauthier, C. A.; Guo, Y.; Mook, R. A.; Rusnak, D. W.; Walker, A. L.; Wood, E. R.; Lackey, K. E. Bioorg. Med. Chem. Lett., 2006, 16(17): 4686.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部